Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk
A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.
Health News is provided as a service to City Drug Pharmacy & Gifts site users by HealthDay. City Drug Pharmacy & Gifts nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.